|
Volumn 4, Issue 37, 2014, Pages 19283-19293
|
The synthesis of non-steroidal anti-inflammatory drug (NSAID)-lantadene prodrugs as novel lung adenocarcinoma inhibitors via the inhibition of cyclooxygenase-2 (COX-2), cyclin D1 and TNF-α-induced NF-κB activation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL PROLIFERATION;
DISEASES;
ESTERIFICATION;
ESTERS;
PLATINUM COMPOUNDS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASES;
DOSE-DEPENDENT MANNER;
LUNG ADENOCARCINOMA A549 CELLS;
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS;
NUCLEAR FACTOR KAPPAB;
PROTEIN EXPRESSIONS;
TUMOR NECROSIS;
BIOLOGICAL ORGANS;
|
EID: 84899799428
PISSN: None
EISSN: 20462069
Source Type: Journal
DOI: 10.1039/c4ra00280f Document Type: Article |
Times cited : (13)
|
References (33)
|